Sandbox:Affan: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 181: | Line 181: | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
| rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: center; |Pigmented lesions | | rowspan="11" style="background: #DCDCDC; padding: 5px; text-align: center; " |Pigmented lesions | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
* Ephelis | * Ephelis | ||
Line 623: | Line 623: | ||
! colspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" + |Soft tissue oral lesions | ! colspan="6" style="background:#4479BA; color: #FFFFFF;" align="center" + |Soft tissue oral lesions | ||
|- | |- | ||
! | ! colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Reactive lesions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Characterstic features | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Characterstic features | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
Line 630: | Line 629: | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
| rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory papillary hyperplasia | | colspan="2" rowspan="1" style="background: #DCDCDC; padding: 5px; text-align: center;" |Inflammatory papillary hyperplasia | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Fibrous hyperplasia | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Fibrous hyperplasia | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucocele | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucocele | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Necrotizing sialometaplasia | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Necrotizing sialometaplasia | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Periodontal abscess | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Periodontal abscess | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Periapical abscess | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Periapical abscess | ||
| | | | ||
| | | | ||
Line 673: | Line 666: | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;"|Epithelial tumors | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Epithelial tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Squamous cell carcinoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Squamous cell carcinoma | ||
| | | | ||
Line 695: | Line 688: | ||
| | | | ||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;"|Papillomas | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Papillomas | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Condyloma acuminatum | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Condyloma acuminatum | ||
| | | | ||
Line 717: | Line 710: | ||
| | | | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;"|Salivary type tumors | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Salivary type tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucoepidermoid carcinoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucoepidermoid carcinoma | ||
| | | | ||
Line 732: | Line 725: | ||
| | | | ||
|- | |- | ||
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;"|Soft tissue and Neural tumors | | rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |Soft tissue and Neural tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Granular cell tumor | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Granular cell tumor | ||
| | | | ||
Line 789: | Line 782: | ||
| | | | ||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;"|Hematolymphoid tumors | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hematolymphoid tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |CD-30 positive lymphoproliferative disorder | | style="background: #DCDCDC; padding: 5px; text-align: center;" |CD-30 positive lymphoproliferative disorder | ||
| | | | ||
Line 818: | Line 811: | ||
| | | | ||
|- | |- | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;"|Tumors of uncertain histiogenesis | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tumors of uncertain histiogenesis | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Congenital granular cell epulis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Congenital granular cell epulis | ||
| | | |
Revision as of 22:33, 11 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Muhammad Affan M.D.[2]
Surface oral lesions | |||||||
---|---|---|---|---|---|---|---|
Oral lesions | Appearance | Associated conditions | Location | Microscopic | Image | ||
White Lesions | Leukoedema |
|
|
|
|
![]() | |
Fordyce granules |
|
|
|
|
![]() | ||
Benign migratoy glossitis |
|
|
|
|
|||
Hairy tongue |
|
|
|
|
![]() | ||
Hairy leukoplakia |
White patches
|
|
|
|
![]() | ||
White sponge nevus |
|
|
|
||||
Lichen Planus |
|
|
|
|
![]() | ||
Frictional hyperkeratosis |
|
|
|
|
![]() | ||
Leukoplakia |
|
|
|
|
![]() | ||
Erythroplakia |
|
|
|
|
![]() | ||
Oral lesions | Characterestic features | Associated conditions | Location | Microscopic | Image | ||
Pigmented lesions |
|
|
|
|
|
![]() | |
|
|
|
|
||||
|
|
|
![]() | ||||
|
|
|
|
|
![]() | ||
|
|
|
|
|
![]() | ||
|
|
|
|
![]() | |||
|
|
|
|
![]() | |||
|
|
Intraorally |
|
![]() | |||
|
|
|
|
||||
|
|
|
|||||
|
|
|
|
![]() | |||
Oral lesions | Characteristic features | Associated conditions | Location | Microscopic | Image | ||
Vesicular/
Ulcerative |
Infections | Herpes simplex virusinfections |
|
|
|
![]() | |
Herpes zoster |
|
|
|
![]() | |||
Hand foot mouth disease |
|
|
![]() | ||||
Infectious mononucliosis |
|
||||||
Erosive lichen planus |
|
||||||
Pseudomembranous candidiasis |
|
||||||
Histoplasmosis |
|
|
|||||
Blastomycosis |
|
|
|||||
Coccidiodomycosis |
|
||||||
Autoimmune conditions | Pemphigus vulgaris |
|
|
||||
Mucous membrane pemphigoid (Cicatricial pemphigoid) |
|
||||||
Aphthous ulcer |
|
||||||
Erythema multiforme |
|
||||||
Sjogren's Syndrome |
Affects salivary and lacrimal glands
|
||||||
Bullous pemphigoid |
|
||||||
Idiopathic conditions | Allergic contact stomatitis |
|
|
||||
Irritant contact stomatitis |
Soft tissue oral lesions | ||||||
---|---|---|---|---|---|---|
Reactive lesions | Characterstic features | Associated conditions | Location | Image | ||
Inflammatory papillary hyperplasia | ||||||
Fibrous hyperplasia | ||||||
Mucocele | ||||||
Necrotizing sialometaplasia | ||||||
Periodontal abscess | ||||||
Periapical abscess | ||||||
Tumors | etiology | location | Clinical appearance | Gold standard/Diagnosis | Image | |
Epithelial tumors | Squamous cell carcinoma | |||||
Oral epithelial dysplasia | ||||||
Proliferative verrucous leukoplakia | ||||||
Papillomas | Condyloma acuminatum | |||||
Verrucous vulgaris | ||||||
Multifocal epithelial hyperplasia | ||||||
Salivary type tumors | Mucoepidermoid carcinoma | |||||
Pleomorphic adenoma | ||||||
Soft tissue and Neural tumors | Granular cell tumor | |||||
Rhabdomyoma | ||||||
Lymphangioma | ||||||
Hemangioma | ||||||
Schwannoma | ||||||
Neurofibroma | ||||||
Kaposi sarcoma | ||||||
Myofibroblastic sarcoma | ||||||
Hematolymphoid tumors | CD-30 positive lymphoproliferative disorder | |||||
Plasmablastic lymphoma | ||||||
Langerhan cell histiocytosis | ||||||
Extramedullary myeloid sarcoma | ||||||
Tumors of uncertain histiogenesis | Congenital granular cell epulis | |||||
Ectomesenchymal chondromyxoid tumor | ||||||
Cysts | Gingival cyst | |||||
Lymphoepithelial cyst | ||||||
Epidermoid cyst | ||||||
Thyroglossal tract cyst | ||||||
Nasolabial cyst |